CA Patent

CA2551474A1 — Medical lipolysis of fat accumulations

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2005-07-14 · 21y expired

What this patent protects

The invention relates to aqueous compositions, comprising at least one phospholipid and/or at least one bile acid and a component such as riboflavin or water, supporting the decomposition of fat, which are suitable for the production of medicaments for the removal of subcutaneous…

USPTO Abstract

The invention relates to aqueous compositions, comprising at least one phospholipid and/or at least one bile acid and a component such as riboflavin or water, supporting the decomposition of fat, which are suitable for the production of medicaments for the removal of subcutaneous fat accumulations and lead to a reduction in the diet-resistant fatty layer.

Drugs covered by this patent

Patent Metadata

Patent number
CA2551474A1
Jurisdiction
CA
Classification
—
Expires
2005-07-14
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.